Robert A. Sorabella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Robert A. Sorabella has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Catherine Wang
College of Physicians and Surgeons of Columbia University, New York, NY, USA
4 shared publications- Isaac George
Division of Cardiac Thoracic & Vascular Surgery New York-Presbyterian Hospital Columbia University Irving Medical Center New York NY USA
4 shared publications Craig Smith
College of Physicians and Surgeons of Columbia University, New York, NY, USA
3 shared publicationsHalit Yerebakan
University of Pennsylvania, Philadelphia, PA, USA
3 shared publications- Marc Najjar
Columbia University College of Physicians and Surgeons, New York, NY, USA
3 shared publications - Michael G. Argenziano
Department of Neurological Surgery, Columbia University Irving Medical Center
3 shared publications
Latest Publications
- 30 December 2024
- Published by Elsevier in The American Journal of Surgery
- Vol. 244, 116161
“Put me in coach”: The psychological benefits of personalized surgical performance coaching on surgery residents
- 30 December 2024
- Published by Elsevier in The American Journal of Surgery
- Vol. 244, 116161
“Put me in coach”: The psychological benefits of personalized surgical performance coaching on surgery residents
- 17 November 2023
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 70 (7) , e92-e96
Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children
Refractory vasodilatory shock (RVS) following massive calcium channel blocker (CCB) overdose remains a challenging clinical entity. Peripheral venoarterial extracorporeal membrane oxygenation (ECMO) has proven useful in several cases of CCB intoxication, however, its use in the pediatric population poses unique challenges given the generally small size of pediatric peripheral vasculature in comparison to the high flow rates necessary for adequate mechanical circulatory support. As a result of these challenges, our group has adopted a “primary” central ECMO cannulation approach to the treatment of children and adolescents admitted to our center with profound RVS after CCB ingestion. We present four cases within the last year using this approach. All patients were successfully discharged from the hospital with no late morbidity at most recent follow-up. Central ECMO support in cases of massive vasodilatory shock following CCB overdose is safe and effective and should be considered early in the clinical course of these critically ill patients.
- 17 November 2023
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 70 (7) , e92-e96
Central Extracorporeal Membrane Oxygenation Support Following Calcium Channel Blocker Overdose in Children
Refractory vasodilatory shock (RVS) following massive calcium channel blocker (CCB) overdose remains a challenging clinical entity. Peripheral venoarterial extracorporeal membrane oxygenation (ECMO) has proven useful in several cases of CCB intoxication, however, its use in the pediatric population poses unique challenges given the generally small size of pediatric peripheral vasculature in comparison to the high flow rates necessary for adequate mechanical circulatory support. As a result of these challenges, our group has adopted a “primary” central ECMO cannulation approach to the treatment of children and adolescents admitted to our center with profound RVS after CCB ingestion. We present four cases within the last year using this approach. All patients were successfully discharged from the hospital with no late morbidity at most recent follow-up. Central ECMO support in cases of massive vasodilatory shock following CCB overdose is safe and effective and should be considered early in the clinical course of these critically ill patients.
- 22 June 2023
- Published by Springer Nature
- p. 255-267
Clinical and Ethical Implications of Adult Cardiac Xenotransplantation
- 22 June 2023
- Published by Springer Nature
- p. 255-267
Clinical and Ethical Implications of Adult Cardiac Xenotransplantation
- 1 January 2023
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 14 (1) , 25-30
Association Between Venous Homografts and Allosensitization After Norwood Procedure
Background: Right ventricle (RV) to pulmonary artery (PA) shunts have become the shunt of choice at many centers for use during the Norwood procedure for single ventricle palliation. Some centers have begun to use cryopreserved femoral or saphenous venous homografts as an alternative to polytetrafluoroethylene (PTFE) for shunt construction. The immunogenicity of these homografts is unknown, and potential allosensitization could have significant implications on transplant candidacy. Methods: All patients undergoing Glenn procedure at our center between 2013 and 2020 were screened. Patients who initially underwent Norwood procedure with either PTFE or venous homograft RV-PA shunt and had available pre-Glenn serum were included in the study. The primary outcome of interest was panel reactive antibody (PRA) level at the time of Glenn surgery. Results: Thirty-six patients met inclusion criteria (N = 28 PTFE, N = 8 homograft). Patients in the homograft group had significantly higher median PRA levels at the time of Glenn surgery (0% [IQR 0-18] PTFE vs 94% [IQR 74-100] homograft, P = .003). There were no other differences between the two groups. Conclusions: Despite potential improvements in PA architecture, the use of venous homografts for RV-PA shunt construction at the time of Norwood procedure is associated with significantly elevated PRA level at the time of Glenn surgery. Centers should carefully consider the use of currently available venous homografts given the high percentage of these patients who may require future transplantation.
- 1 January 2023
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 14 (1) , 25-30
Association Between Venous Homografts and Allosensitization After Norwood Procedure
Background: Right ventricle (RV) to pulmonary artery (PA) shunts have become the shunt of choice at many centers for use during the Norwood procedure for single ventricle palliation. Some centers have begun to use cryopreserved femoral or saphenous venous homografts as an alternative to polytetrafluoroethylene (PTFE) for shunt construction. The immunogenicity of these homografts is unknown, and potential allosensitization could have significant implications on transplant candidacy. Methods: All patients undergoing Glenn procedure at our center between 2013 and 2020 were screened. Patients who initially underwent Norwood procedure with either PTFE or venous homograft RV-PA shunt and had available pre-Glenn serum were included in the study. The primary outcome of interest was panel reactive antibody (PRA) level at the time of Glenn surgery. Results: Thirty-six patients met inclusion criteria (N = 28 PTFE, N = 8 homograft). Patients in the homograft group had significantly higher median PRA levels at the time of Glenn surgery (0% [IQR 0-18] PTFE vs 94% [IQR 74-100] homograft, P = .003). There were no other differences between the two groups. Conclusions: Despite potential improvements in PA architecture, the use of venous homografts for RV-PA shunt construction at the time of Norwood procedure is associated with significantly elevated PRA level at the time of Glenn surgery. Centers should carefully consider the use of currently available venous homografts given the high percentage of these patients who may require future transplantation.
- 19 March 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 223 (5) , 839-840
General surgical procedures in survivors of complex congenital heart disease: A potential Pandora's box?
- 19 March 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 223 (5) , 839-840
General surgical procedures in survivors of complex congenital heart disease: A potential Pandora's box?
- 17 December 2021
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 13 (1) , 46-52
Outcomes in Pediatric Post-Cardiotomy ECMO Support With Modification of Systematic Support Strategy
Utilization of extracorporeal membrane oxygenation (ECMO) support in the post-cardiotomy setting is vital to successful perioperative outcomes following pediatric cardiac surgery. Specific analysis of protocolized management strategies and staff preparedness is imperative to optimizing institutional ECMO outcomes. All patients requiring post-cardiotomy ECMO support at a single institution from 2013 to 2019 were retrospectively reviewed. In 2015, several modifications were made to the ECMO support paradigm that addressed deficiencies in equipment, critical care protocols, and staff preparedness. Cases were stratified according to era of ECMO support; patients supported prior to paradigm change from 2013 to 2015 (Group EARLY, n = 20), and patients supported following the implementation of systematic modifications from 2016 to 2019 (Group LATE, n = 26). The primary outcomes of interest were survival to decannulation and hospital discharge. Median age at cannulation was 24.5 days (IQR 7-96) and median duration of support was 4 days (IQR 2-8). Overall survival to decannulation was 78.3% (65% EARLY vs. 88.5% LATE, P = .08) and overall survival to hospital discharge was 58.7% (35% EARLY vs. 76.9% LATE, P = .004). Systematic modifications to ECMO support strategy and staff preparation are associated with a significant increase in perioperative survival for pediatric patients requiring post-cardiotomy ECMO support.
- 17 December 2021
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 13 (1) , 46-52
Outcomes in Pediatric Post-Cardiotomy ECMO Support With Modification of Systematic Support Strategy
Utilization of extracorporeal membrane oxygenation (ECMO) support in the post-cardiotomy setting is vital to successful perioperative outcomes following pediatric cardiac surgery. Specific analysis of protocolized management strategies and staff preparedness is imperative to optimizing institutional ECMO outcomes. All patients requiring post-cardiotomy ECMO support at a single institution from 2013 to 2019 were retrospectively reviewed. In 2015, several modifications were made to the ECMO support paradigm that addressed deficiencies in equipment, critical care protocols, and staff preparedness. Cases were stratified according to era of ECMO support; patients supported prior to paradigm change from 2013 to 2015 (Group EARLY, n = 20), and patients supported following the implementation of systematic modifications from 2016 to 2019 (Group LATE, n = 26). The primary outcomes of interest were survival to decannulation and hospital discharge. Median age at cannulation was 24.5 days (IQR 7-96) and median duration of support was 4 days (IQR 2-8). Overall survival to decannulation was 78.3% (65% EARLY vs. 88.5% LATE, P = .08) and overall survival to hospital discharge was 58.7% (35% EARLY vs. 76.9% LATE, P = .004). Systematic modifications to ECMO support strategy and staff preparation are associated with a significant increase in perioperative survival for pediatric patients requiring post-cardiotomy ECMO support.